Table 1.
Baseline characteristics.
| Variable | 7 October 2022–7 January 2023 (N = 261) |
7 October 2023–7 January 2024 (N = 295) |
p-Value |
|---|---|---|---|
| Age (years) | 69 (58–79) | 70 (59–80) | 0.7 |
| Female sex | 78 (29.9%) | 106 (35.9%) | 0.155 |
| BMI (kg/m2) | 27.3 (24.2–31) | 27.4 (24.2–30.4) | 0.543 |
| Ethnicity—no. (%) | <0.001 | ||
| Jews | 197 (75.5%) | 256 (86.8%) | |
| Arabs | 57 (21.8%) | 39 (13.2%) | |
| Other | 7 (2.7%) | 0 (0%) | |
| HTN—no. (%) | 156 (59.8%) | 155 (52.5%) | 0.113 |
| DLP—no. (%) | 139 (53.3%) | 145 (49.2%) | 0.378 |
| DM—no. (%) | 98 (37.5%) | 102 (34.6%) | 0.522 |
| PAD—no. (%) | 19 (7.3%) | 17(5.8%) | 0.58 |
| CHF—no. (%) | 39 (14.9%) | 49 (16.6%) | 0.674 |
| PHTN—no. (%) | 5 (1.9%) | 25 (8.5%) | <0.001 |
| AFIB—no. (%) | 39 (14.9%) | 54 (18.3%) | 0.344 |
| Prior MI—no. (%) | 98 (37.5%) | 95 (32.2%) | 0.218 |
| Prior CABG—no. (%) | 24 (9.2%) | 32 (10.8%) | 0.614 |
| COPD—no. (%) | 27 (10.3%) | 18 (6.1%) | 0.09 |
| CKD—no. (%) | 31 (11.9%) | 30 (10.2%) | 0.612 |
| Prior stroke—no. (%) | 17 (6.5%) | 15 (5.1%) | 0.59 |
| Smoking—no. (%) | 74 (28.4%) | 66 (22.4%) | 0.171 |
| Family History of CAD—no. (%) | 18 (6.9%) | 23 (7.8%) | 0.808 |
Values are the median (interquartile range: [Q1–Q3]) for continuous variables and the number of occurrences (frequency %) for categorical variables. AFIB = atrial fibrillation; BMI = body mass index; CABG = coronary artery bypass graft surgery; CAD = coronary artery disease; CHF = congestive heart failure; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; DLP = dyslipidemia; DM = diabetes mellitus; HTN = hypertension; MI = myocardial infraction; PAD = peripheral artery disease; PHTN = pulmonary hypertension.